Search

Your search keyword '"Ausems, M.G.E.M."' showing total 326 results

Search Constraints

Start Over You searched for: Author "Ausems, M.G.E.M." Remove constraint Author: "Ausems, M.G.E.M."
326 results on '"Ausems, M.G.E.M."'

Search Results

51. Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility

53. Preferences to Receive Unsolicited Findings of Germline Genome Sequencing in a Large Population of Cancer Patients

54. Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance

55. MEN1-dependent breast cancer: Indication for early screening? Results from the Dutch MEN1 study group

56. Performance of BRCA1/2 mutation prediction models in male breast cancer patients

57. Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing

58. Homozygosity mapping of a Desbuquois dysplasia locus to chromosome 17q25.3. (Short Report)

59. BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk

60. Performance of BRCA1/ 2 mutation prediction models in male breast cancer patients

61. Unsolicited findings of next-generation sequencing for tumor analysis within a Dutch consortium: Clinical daily practice reconsidered

62. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

63. Recurrent candidiasis and early-onset gastric cancer in a patient with a genetically defined partial MYD88 defect

64. Clinical and molecular cytogenetic studies in a case with partial trisomy 12p due to a de novo supernumerary ring chromosome

66. Improved Overall Survival after Contralateral Risk-Reducing Mastectomy in Brca1/2 Mutation Carriers with a History of Unilateral Breast Cancer: A Prospective Analysis

67. Variation in Mutation Spectrum Partly Explains Regional Differences in the Breast Cancer Risk of Female BRCA Mutation Carriers in the Netherlands

69. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers

70. Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study

71. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

72. Repeated nipple fluid aspiration

73. Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers

76. Homozygous deletion of exon 18 leads to degradation of the lysosomal alpha-glucosidase precursor and to the infantile form of glycogen storage disease type II

77. Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

78. Breast cancer risk and 6q22.33: Combined results from breast cancer association consortium and consortium of investigators on modifiers of brca1/2

79. Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2

80. Distress in partners of individuals diagnosed with or at high risk of developing tumors due to rare hereditary cancer syndromes

81. Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers

82. Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers

83. Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations

84. Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: Results from the initial screening round of the IMPACT study

85. Does and should breast cancer genetic counselling include lifestyle advice?

86. Journal of Genetic Counseling: counselees’ post-visit satisfaction, cognitions, anxiety, and needs fulfillment

87. BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy

88. [DNA-based diagnosis of hereditary tumour predisposition]

89. Tailoring communication in cancer genetic counseling through individual video-supported feedback: A controlled pretest–posttest design

90. Initial cancer genetic counseling consultation: change in counselees’ cognitions and anxiety, and association with addressing their needs and preferences

91. Communication in cancer genetic counselling: does it reflect counselees’ previsit needs and preferences?

94. Acceptance of genetic counseling and testing in a hospital-based series of patients with gynecological cancer

96. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

97. Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk

98. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

99. Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): A multicentre randomized controlled trial

100. Breast cancer risk and 6q22.33: Combined results from breast cancer association consortium and consortium of investigators on modifiers of brca1/2

Catalog

Books, media, physical & digital resources